{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T15:56:24Z","timestamp":1776441384998,"version":"3.51.2"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,17]]},"DOI":"10.7759\/cureus.107234","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T14:51:58Z","timestamp":1776437518000},"source":"Crossref","is-referenced-by-count":0,"title":["Post-inflammatory Hyperpigmentation in Skin of Color: Emerging Therapies and Treatment Algorithms"],"prefix":"10.7759","author":[{"given":"Calista","family":"Persson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roma","family":"Desai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christo","family":"Manikkuttiyil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harleen","family":"Multani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raven","family":"Lirio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikaela","family":"Nueva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roksana","family":"Hesari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akhil","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4103\/ds.ds-d-23-00184","article-title":"Efficacy and safety of cysteamine-isobionicamide complex in postinflammatory hyperpigmentation: a 16-week randomized double-blinded vehicle-controlled trial","volume":"41","author":"Liu RTL","year":"2023","unstructured":"Liu RTL, Tsai TF, Lai YJ, Ng C. Efficacy and safety of cysteamine-isobionicamide complex in postinflammatory hyperpigmentation: a 16-week randomized double-blinded vehicle-controlled trial. Dermatol Sinica. 2023, 41:222-30. 10.4103\/ds.ds-d-23-00184","journal-title":"Dermatol Sinica"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.15786","article-title":"The clinical benefit of a multimodal topical approach to treating skin dyspigmentation","volume":"22","author":"Draelos ZD","year":"2023","unstructured":"Draelos ZD, Diaz I. The clinical benefit of a multimodal topical approach to treating skin dyspigmentation. J Cosmet Dermatol. 2023, 22:1799-804. 10.1111\/jocd.15786","journal-title":"J Cosmet Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.03.001","article-title":"Oral tranexamic acid (TA) in the treatment of melasma: a retrospective analysis","volume":"75","author":"Lee HC","year":"2016","unstructured":"Lee HC, Thng TG, Goh CL. Oral tranexamic acid (TA) in the treatment of melasma: a retrospective analysis. J Am Acad Dermatol. 2016, 75:385-92. 10.1016\/j.jaad.2016.03.001","journal-title":"J Am Acad Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.13755","article-title":"A case report on the use of topical cysteamine 5% cream in the management of refractory postinflammatory hyperpigmentation (PIH) resistant to triple combination cream (hydroquinone, topical corticosteroids, and retinoids)","volume":"20","author":"Mathe N","year":"2021","unstructured":"Mathe N, Balogun M, Yoo J. A case report on the use of topical cysteamine 5% cream in the management of refractory postinflammatory hyperpigmentation (PIH) resistant to triple combination cream (hydroquinone, topical corticosteroids, and retinoids). J Cosmet Dermatol. 2021, 20:204-6. 10.1111\/jocd.13755","journal-title":"J Cosmet Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-021-00643-2","article-title":"Effects of topical retinoids on acne and post-inflammatory hyperpigmentation in patients with skin of color: a clinical review and implications for practice","volume":"23","author":"Callender VD","year":"2022","unstructured":"Callender VD, Baldwin H, Cook-Bolden FE, Alexis AF, Stein Gold L, Guenin E. Effects of topical retinoids on acne and post-inflammatory hyperpigmentation in patients with skin of color: a clinical review and implications for practice. Am J Clin Dermatol. 2022, 23:69-81. 10.1007\/s40257-021-00643-2","journal-title":"Am J Clin Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.36849\/JDD.6485","article-title":"Getting to the core of contemporary therapies for post-inflammatory hyperpigmentation","volume":"21","author":"Naik PP","year":"2022","unstructured":"Naik PP. Getting to the core of contemporary therapies for post-inflammatory hyperpigmentation. J Drugs Dermatol. 2022, 21:276-83. 10.36849\/JDD.6485","journal-title":"J Drugs Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.36849\/JDD.2020.4887","article-title":"Post-inflammatory hyperpigmentation: a review of treatment strategies","volume":"19","author":"Shenoy A","year":"2020","unstructured":"Shenoy A, Madan R. Post-inflammatory hyperpigmentation: a review of treatment strategies. J Drugs Dermatol. 2020, 19:763-8. 10.36849\/JDD.2020.4887","journal-title":"J Drugs Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.12747","article-title":"The role of systemic treatments for skin lightening","volume":"17","author":"Juhasz ML","year":"2018","unstructured":"Juhasz ML, Levin MK. The role of systemic treatments for skin lightening. J Cosmet Dermatol. 2018, 17:1144-57. 10.1111\/jocd.12747","journal-title":"J Cosmet Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.14494","article-title":"Efficacy of topical cysteamine hydrochloride in treating melasma: a systematic review","volume":"20","author":"Ahramiyanpour N","year":"2021","unstructured":"Ahramiyanpour N, Saki N, Akbari Z, Shamsi-Meymandi S, Amiri R, Heiran A. Efficacy of topical cysteamine hydrochloride in treating melasma: a systematic review. J Cosmet Dermatol. 2021, 20:3593-602. 10.1111\/jocd.14494","journal-title":"J Cosmet Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.14447","article-title":"An open-label study assessing the efficacy and tolerability of a skincare regimen in subjects of different ethnicities with moderate-to-severe hyperpigmentation","volume":"21","author":"Wenner K","year":"2022","unstructured":"Wenner K, Ramberg T. An open-label study assessing the efficacy and tolerability of a skincare regimen in subjects of different ethnicities with moderate-to-severe hyperpigmentation. J Cosmet Dermatol. 2022, 21:2497-507. 10.1111\/jocd.14447","journal-title":"J Cosmet Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-022-00780-4","article-title":"Update on melasma-part II: treatment","volume":"12","author":"Cassiano DP","year":"2022","unstructured":"Cassiano DP, Esp\u00f3sito AC, da Silva CN, et al.. Update on melasma-part II: treatment. Dermatol Ther (Heidelb). 2022, 12:1989-2012. 10.1007\/s13555-022-00780-4","journal-title":"Dermatol Ther (Heidelb)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-023-00759-7","article-title":"Review of laser treatments for post-inflammatory hyperpigmentation in skin of color","volume":"24","author":"Sowash M","year":"2023","unstructured":"Sowash M, Alster T. Review of laser treatments for post-inflammatory hyperpigmentation in skin of color. Am J Clin Dermatol. 2023, 24:381-96. 10.1007\/s40257-023-00759-7","journal-title":"Am J Clin Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2024.08.009","article-title":"Innovations in hyperpigmentation","volume":"43","author":"Obeng-Nyarko CN","year":"2025","unstructured":"Obeng-Nyarko CN, Puerta Durango KS, Jackson S, Taylor SC. Innovations in hyperpigmentation. Dermatol Clin. 2025, 43:111-21. 10.1016\/j.det.2024.08.009","journal-title":"Dermatol Clin"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.14432","article-title":"Prevention of post-inflammatory hyperpigmentation in skin of colour: a systematic review","volume":"66","author":"Mar K","year":"2025","unstructured":"Mar K, Maazi M, Khalid B, Ahmed R, Wang OJ, Khosravi-Hafshejani T. Prevention of post-inflammatory hyperpigmentation in skin of colour: a systematic review. Australas J Dermatol. 2025, 66:119-26. 10.1111\/ajd.14432","journal-title":"Australas J Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/pcmr.12986","article-title":"Management of hyperpigmentation: current treatments and emerging therapies","volume":"34","author":"Nautiyal A","year":"2021","unstructured":"Nautiyal A, Wairkar S. Management of hyperpigmentation: current treatments and emerging therapies. Pigment Cell Melanoma Res. 2021, 34:1000-14. 10.1111\/pcmr.12986","journal-title":"Pigment Cell Melanoma Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.64550\/joid.8hakh229","article-title":"Integrative approaches to hyperpigmentation therapy","volume":"1","author":"Shah S","year":"2022","unstructured":"Shah S, Shah RM, Patel S, Patel S, Doshi S, Lio P. Integrative approaches to hyperpigmentation therapy. J Integr Dermatol. 2022, 1:1-19. 10.64550\/joid.8hakh229","journal-title":"J Integr Dermatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/jvc2.385","article-title":"A practical guide to over-the-counter treatments for hyperpigmentation","volume":"3","author":"Jafry M","year":"2024","unstructured":"Jafry M, Guan LL, Mohammad TF. A practical guide to over-the-counter treatments for hyperpigmentation. JEADV Clin Pract. 2024, 3:433-47. 10.1002\/jvc2.385","journal-title":"JEADV Clin Pract"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1177\/12034754241265716","article-title":"Treatment of post-inflammatory hyperpigmentation in skin of colour: a systematic review","volume":"28","author":"Mar K","year":"2024","unstructured":"Mar K, Khalid B, Maazi M, Ahmed R, Wang OJ, Khosravi-Hafshejani T. Treatment of post-inflammatory hyperpigmentation in skin of colour: a systematic review. J Cutan Med Surg. 2024, 28:473-80. 10.1177\/12034754241265716","journal-title":"J Cutan Med Surg"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-70419-7_14","article-title":"Post-inflammatory hyperpigmentation","author":"Rodrigues M","year":"2018","unstructured":"Rodrigues M, Ayala-Cort\u00e9s AS. Post-inflammatory hyperpigmentation. Pigmentary Disorders. Springer, Cham, Switzerland; 2018. 4:197-208. 10.1007\/978-3-319-70419-7_14"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-2522720\/v1","article-title":"Impact of postinflammatory hyperpigmentation on quality of life in patients with skin of color","volume":"4","author":"Bhattacharya I","year":"2024","unstructured":"Bhattacharya I, Dsouza P, Dhaka K. Impact of postinflammatory hyperpigmentation on quality of life in patients with skin of color. Pigment Int. 2024, 4:32-4. 10.21203\/rs.3.rs-2522720\/v1","journal-title":"Pigment Int"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.20473\/BIKKK.V28.3.2016.243-250","article-title":"Treatment options for postinflammatory hyperpigmentation in color skin","volume":"28","author":"Wardhani PH","year":"2017","unstructured":"Wardhani PH, Rahmadewi R. Treatment options for postinflammatory hyperpigmentation in color skin. Berk Ilmu Kesehat Kulit Kelamin. 2017, 28:243-50. 10.20473\/BIKKK.V28.3.2016.243-250","journal-title":"Berk Ilmu Kesehat Kulit Kelamin"},{"key":"ref23","article-title":"Managing postinflammatory hyperpigmentation in pediatric patients with skin of color","volume":"103","author":"Heath CR","year":"2019","unstructured":"Heath CR. Managing postinflammatory hyperpigmentation in pediatric patients with skin of color. Cutis. 2019, 103:71-3.","journal-title":"Cutis"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.20804","article-title":"An in\u00a0vivo model of postinflammatory hyperpigmentation and erythema: clinical, colorimetric and molecular characteristics","volume":"186","author":"Vellaichamy G","year":"2022","unstructured":"Vellaichamy G, Kohli I, Zubair R, et al.. An in\u00a0vivo model of postinflammatory hyperpigmentation and erythema: clinical, colorimetric and molecular characteristics. Br J Dermatol. 2022, 186:508-19. 10.1111\/bjd.20804","journal-title":"Br J Dermatol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.36849\/JDD.8146","article-title":"Postinflammatory hyperpigmentation following Mohs micrographic surgery: an observational study","volume":"23","author":"Hossain OB","year":"2024","unstructured":"Hossain OB, Labiak A, Mieczkowska K, Srikantha R, Ciocon DH, Williams RF. Postinflammatory hyperpigmentation following Mohs micrographic surgery: an observational study. J Drugs Dermatol. 2024, 23:316-21. 10.36849\/JDD.8146","journal-title":"J Drugs Dermatol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.7573\/dic.2021-11-2","article-title":"Dermatology: how to manage facial hyperpigmentation in skin of colour","volume":"11","author":"Moolla S","year":"2022","unstructured":"Moolla S, Miller-Monthrope Y. Dermatology: how to manage facial hyperpigmentation in skin of colour. Drugs Context. 2022, 11:23-5. 10.7573\/dic.2021-11-2","journal-title":"Drugs Context"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2668","article-title":"Efficacy and safety of tranexamic acid in melasma: a meta-analysis and systematic review","volume":"97","author":"Kim HJ","year":"2017","unstructured":"Kim HJ, Moon SH, Cho SH, Lee JD, Kim HS. Efficacy and safety of tranexamic acid in melasma: a meta-analysis and systematic review. Acta Derm Venereol. 2017, 97:776-81. 10.2340\/00015555-2668","journal-title":"Acta Derm Venereol"},{"key":"ref28","article-title":"Postinflammatory hyperpigmentation in patients with skin of color","volume":"97","author":"Shokeen D","year":"2016","unstructured":"Shokeen D. Postinflammatory hyperpigmentation in patients with skin of color. Cutis. 2016, 97:E9-11.","journal-title":"Cutis"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1002\/jvc2.378","article-title":"Hyperpigmentation in skin of colour: therapeutic benefits of thiamidol","volume":"4","author":"Schuster B","year":"2024","unstructured":"Schuster B, Sammain A. Hyperpigmentation in skin of colour: therapeutic benefits of thiamidol. JEADV Clin Pract. 2024, 4:23-5. 10.1002\/jvc2.378","journal-title":"JEADV Clin Pract"},{"key":"ref30","article-title":"Getting to the core of contemporary therapies for post-inflammatory hyperpigmentation","volume":"21","author":"St\u00fclke J","year":"2022","unstructured":"St\u00fclke J. Getting to the core of contemporary therapies for post-inflammatory hyperpigmentation. J Drugs Dermatol. 2022, 21:276-83.","journal-title":"J Drugs Dermatol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.22541\/AU.162083032.29238570\/V1","article-title":"Post-inflammatory hyperpigmentation of the skin","volume":"2","author":"Diamandis D","year":"2021","unstructured":"Diamandis D, Seideman D, Makris A. Post-inflammatory hyperpigmentation of the skin. Authorea. 2021, 2:16-8. 10.22541\/AU.162083032.29238570\/V1","journal-title":"Authorea"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5560386","article-title":"1927\u2009nm thulium laser successfully treats postinflammatory hyperpigmentation in skin of color","volume":"2021","author":"Alharbi MA","year":"2021","unstructured":"Alharbi MA. 1927\u2009nm thulium laser successfully treats postinflammatory hyperpigmentation in skin of color. Dermatol Res Pract. 2021, 2021:5560386. 10.1155\/2021\/5560386","journal-title":"Dermatol Res Pract"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1177\/1203475420957633","article-title":"Prophylaxis of post-inflammatory hyperpigmentation from energy-based device treatments: a review","volume":"25","author":"Wong IT","year":"2021","unstructured":"Wong IT, Richer V. Prophylaxis of post-inflammatory hyperpigmentation from energy-based device treatments: a review. J Cutan Med Surg. 2021, 25:77-86. 10.1177\/1203475420957633","journal-title":"J Cutan Med Surg"},{"key":"ref34","article-title":"Therapeutic insights in melasma and hyperpigmentation management","volume":"18","author":"Huerth KA","year":"2019","unstructured":"Huerth KA, Hassan S, Callender VD. Therapeutic insights in melasma and hyperpigmentation management. J Drugs Dermatol. 2019, 18:718-29.","journal-title":"J Drugs Dermatol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-021-02239-6","article-title":"Postinflammatory hyperpigmentation: protocol for development of a core outcome set for clinical trials","volume":"314","author":"Kang BY","year":"2022","unstructured":"Kang BY, Ibrahim SA, Shokeen D, et al.. Postinflammatory hyperpigmentation: protocol for development of a core outcome set for clinical trials. Arch Dermatol Res. 2022, 314:357-61. 10.1007\/s00403-021-02239-6","journal-title":"Arch Dermatol Res"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2020.1793892","article-title":"Postinflammatory hypopigmentation: a comprehensive review of treatments","volume":"33","author":"Madu PN","year":"2022","unstructured":"Madu PN, Syder N, Elbuluk N. Postinflammatory hypopigmentation: a comprehensive review of treatments. J Dermatolog Treat. 2022, 33:704-8. 10.1080\/09546634.2020.1793892","journal-title":"J Dermatolog Treat"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.19566","article-title":"Post-inflammatory hyperpigmentation: a systematic review of treatment outcomes","volume":"38","author":"Kashetsky N","year":"2024","unstructured":"Kashetsky N, Feschuk A, Pratt ME. Post-inflammatory hyperpigmentation: a systematic review of treatment outcomes. J Eur Acad Dermatol Venereol. 2024, 38:470-9. 10.1111\/jdv.19566","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref38","article-title":"Combination chemical peels with topical pigmentation therapy in skin of color","volume":"16","author":"Downie J","year":"2017","unstructured":"Downie J, Schneider K, Goberdhan LT, Makino ET, Mehta RC. Combination chemical peels with topical pigmentation therapy in skin of color. J Drugs Dermatol. 2017, 16:301-6.","journal-title":"J Drugs Dermatol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000001007","article-title":"Treatment of postinflammatory hyperpigmentation with a combination of glycolic acid peels and a topical regimen in dark-skinned patients: a comparative study","volume":"43","author":"Sarkar R","year":"2017","unstructured":"Sarkar R, Parmar NV, Kapoor S. Treatment of postinflammatory hyperpigmentation with a combination of glycolic acid peels and a topical regimen in dark-skinned patients: a comparative study. Dermatol Surg. 2017, 43:566-73. 10.1097\/DSS.0000000000001007","journal-title":"Dermatol Surg"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.9734\/jpri\/2021\/v33i63a35864","article-title":"Overview on post-inflammatory hyperpigmentation","volume":"33","author":"Albahlool AM","year":"2021","unstructured":"Albahlool AM, Alshehri OKM, Alrasheed SM, Al Ali MA, Al Sharif AOR. Overview on post-inflammatory hyperpigmentation. J Pharm Res Int. 2021, 33:1-9. 10.9734\/jpri\/2021\/v33i63a35864","journal-title":"J Pharm Res Int"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.4103\/ijd.IJD_295_18","article-title":"The role of sunscreen in melasma and postinflammatory hyperpigmentation","volume":"65","author":"Fatima S","year":"2020","unstructured":"Fatima S, Braunberger T, Mohammad TF, Kohli I, Hamzavi IH. The role of sunscreen in melasma and postinflammatory hyperpigmentation. Indian J Dermatol. 2020, 65:5-10. 10.4103\/ijd.IJD_295_18","journal-title":"Indian J Dermatol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.33590\/emj\/pcmj2598","article-title":"Clinical practice insights for hyperpigmentation treatment","volume":"4","author":"Barrell A","year":"2024","unstructured":"Barrell A. Clinical practice insights for hyperpigmentation treatment. Eur Med J. 2024, 4:30-8. 10.33590\/emj\/pcmj2598","journal-title":"Eur Med J"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdrv.2025.03.003","article-title":"The first twenty years of skin of color dermatology: an era of advancements in skin, hair and nail disorders","volume":"4","author":"Desir N","year":"2025","unstructured":"Desir N, Encarnacion IN, Hamid A, Turner K, Oyasiji O, Elbuluk NM, Taylor SC. The first twenty years of skin of color dermatology: an era of advancements in skin, hair and nail disorders. JAAD Rev. 2025, 4:69-82. 10.1016\/j.jdrv.2025.03.003","journal-title":"JAAD Rev"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.33192\/smj.v77i3.271926","article-title":"Platelet-rich plasma as a potential treatment for melasma: a review","volume":"77","author":"Valentina S","year":"2025","unstructured":"Valentina S, Laksemi DAAS. Platelet-rich plasma as a potential treatment for melasma: a review. Siriraj Med J. 2025, 77:239-49. 10.33192\/smj.v77i3.271926","journal-title":"Siriraj Med J"},{"key":"ref45","article-title":"Vitiligo, melasma, PIH, and albinism: clinical update and emerging therapies","volume":"46","author":"Urbonas R","year":"2025","unstructured":"Urbonas R, Jilani S, Cohen B. Vitiligo, melasma, PIH, and albinism: clinical update and emerging therapies. Dermatol Times. 2025, 46:14-6.","journal-title":"Dermatol Times"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S508522","article-title":"Clinical efficacy of microplasma radiofrequency in treating post-traumatic pigmentary deposition: a VISIA quantitative analysis","volume":"21","author":"Xu Y","year":"2025","unstructured":"Xu Y, Yin Y, Yang ZQ, Li J, Guo LN, Ma C. Clinical efficacy of microplasma radiofrequency in treating post-traumatic pigmentary deposition: a VISIA quantitative analysis. Ther Clin Risk Manag. 2025, 21:575-82. 10.2147\/TCRM.S508522","journal-title":"Ther Clin Risk Manag"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1089\/photob.2021.0086","article-title":"Laser-assisted drug delivery of tranexamic acid by picosecond laser in postinflammatory hyperpigmentation: a split-area double-blind randomized prospective study","volume":"39","author":"Lin CH","year":"2021","unstructured":"Lin CH, Tsai YJ, Lin KC, et al.. Laser-assisted drug delivery of tranexamic acid by picosecond laser in postinflammatory hyperpigmentation: a split-area double-blind randomized prospective study. Photobiomodul Photomed Laser Surg. 2021, 39:711-5. 10.1089\/photob.2021.0086","journal-title":"Photobiomodul Photomed Laser Surg"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2023.2361106","article-title":"Tranexamic acid as a therapeutic option for melasma management: meta-analysis and systematic review of randomized controlled trials","volume":"35","author":"Calacattawi R","year":"2024","unstructured":"Calacattawi R, Alshahrani M, Aleid M, Aleid F, Basamih K, Alsugair G, Alotibi N. Tranexamic acid as a therapeutic option for melasma management: meta-analysis and systematic review of randomized controlled trials. J Dermatolog Treat. 2024, 35:2361106. 10.1080\/09546634.2023.2361106","journal-title":"J Dermatolog Treat"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-017-0263-8","article-title":"Tranexamic acid in the treatment of melasma: a review of the literature","volume":"18","author":"Perper M","year":"2017","unstructured":"Perper M, Eber AE, Fayne R, Verne SH, Magno RJ, Cervantes J, Nouri K. Tranexamic acid in the treatment of melasma: a review of the literature. Am J Clin Dermatol. 2017, 18:373-81. 10.1007\/s40257-017-0263-8","journal-title":"Am J Clin Dermatol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.16160","article-title":"The uses of tranexamic acid in dermatology: a review","volume":"62","author":"Kim KM","year":"2023","unstructured":"Kim KM, Lim HW. The uses of tranexamic acid in dermatology: a review. Int J Dermatol. 2023, 62:589-98. 10.1111\/ijd.16160","journal-title":"Int J Dermatol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S455229","article-title":"Tranexamic acid for the treatment of hyperpigmentation and telangiectatic disorders other than melasma: an update","volume":"5","author":"Chen T","year":"2024","unstructured":"Chen T, Xue J, Wang Q. Tranexamic acid for the treatment of hyperpigmentation and telangiectatic disorders other than melasma: an update. Clin Cosmet Investig Dermatol. 2024, 5:2151-63. 10.2147\/CCID.S455229","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S128339","article-title":"Glutathione and its antiaging and antimelanogenic effects","volume":"10","author":"Weschawalit S","year":"2017","unstructured":"Weschawalit S, Thongthip S, Phutrakool P, Asawanonda P. Glutathione and its antiaging and antimelanogenic effects. Clin Cosmet Investig Dermatol. 2017, 10:147-53. 10.2147\/CCID.S128339","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.37349\/emed.2022.00117","article-title":"Antioxidant and photoprotective potential of Polypodium leucotomos","volume":"3","author":"Santa Cruz RYM","year":"2022","unstructured":"Santa Cruz RYM, Ar\u00e9valo SV, Rashid A, Jara MRA, Aurora-Prado M. Antioxidant and photoprotective potential of Polypodium leucotomos. Explor Med. 2022, 3:607-16. 10.37349\/emed.2022.00117","journal-title":"Explor Med"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16896","article-title":"French maritime pine bark extract (pycnogenol) in association with triple combination cream for the treatment of facial melasma in women: a double-blind, randomized, placebo-controlled trial","volume":"35","author":"Lima PB","year":"2021","unstructured":"Lima PB, Dias JA, Esposito AC, Miot LD, Miot HA. French maritime pine bark extract (pycnogenol) in association with triple combination cream for the treatment of facial melasma in women: a double-blind, randomized, placebo-controlled trial. J Eur Acad Dermatol Venereol. 2021, 35:502-8. 10.1111\/jdv.16896","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.16741","article-title":"Clinical trials conducted on herbal remedies for the treatment of melasma: a scoping review","volume":"24","author":"Parvizi MM","year":"2025","unstructured":"Parvizi MM, Hekmat M, Yousefi N, Javaheri R, Mehrzadeh A, Saki N. Clinical trials conducted on herbal remedies for the treatment of melasma: a scoping review. J Cosmet Dermatol. 2025, 24:e16741. 10.1111\/jocd.16741","journal-title":"J Cosmet Dermatol"},{"key":"ref56","article-title":"Nonablative fractional laser resurfacing in skin of color: evidence-based review","volume":"10","author":"Kaushik SB","year":"2017","unstructured":"Kaushik SB, Alexis AF. Nonablative fractional laser resurfacing in skin of color: evidence-based review. J Clin Aesthet Dermatol. 2017, 10:51-67.","journal-title":"J Clin Aesthet Dermatol"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.4103\/0974-2077.104912","article-title":"Chemical peels for melasma in dark-skinned patients","volume":"5","author":"Sarkar R","year":"2012","unstructured":"Sarkar R, Bansal S, Garg VK. Chemical peels for melasma in dark-skinned patients. J Cutan Aesthet Surg. 2012, 5:247-53. 10.4103\/0974-2077.104912","journal-title":"J Cutan Aesthet Surg"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-021-00603-1","article-title":"Light-based devices for the treatment of facial erythema and telangiectasia","volume":"4","author":"Yepuri V","year":"2021","unstructured":"Yepuri V, Patil AD, Fritz K, Salavastru C, Kroumpouzos G, Nistic\u00f2 SP, Goldust M. Light-based devices for the treatment of facial erythema and telangiectasia. Dermatol Ther. 2021, 4:26-8. 10.1007\/s13555-021-00603-1","journal-title":"Dermatol Ther"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14615-1","article-title":"Pulsed-dye laser treatment for inflammatory acne vulgaris: randomized controlled trial","volume":"362","author":"Seaton ED","year":"2003","unstructured":"Seaton ED, Charakida A, Mouser PE, Grace I, Clement RM, Chu AC. Pulsed-dye laser treatment for inflammatory acne vulgaris: randomized controlled trial. Lancet. 2003, 362:1347-52. 10.1016\/S0140-6736(03)14615-1","journal-title":"Lancet"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.22603","article-title":"Side effects from intense pulsed light: Importance of skin pigmentation, fluence level and ultraviolet radiation\u2014a randomized controlled trial","volume":"49","author":"Thaysen-Petersen D","year":"2017","unstructured":"Thaysen-Petersen D, Erlendsson AM, Nash JF, Beerwerth F, Philipsen PA, Wulf HC, Haedersdal M. Side effects from intense pulsed light: Importance of skin pigmentation, fluence level and ultraviolet radiation\u2014a randomized controlled trial. Lasers Surg Med. 2017, 49:88-96. 10.1002\/lsm.22603","journal-title":"Lasers Surg Med"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12050","article-title":"A focused review on acne-induced and aesthetic procedure-related postinflammatory hyperpigmentation in Asians","volume":"27 Suppl 1","author":"Eimpunth S","year":"2013","unstructured":"Eimpunth S, Wanitphadeedecha R, Manuskiatti W. A focused review on acne-induced and aesthetic procedure-related postinflammatory hyperpigmentation in Asians. J Eur Acad Dermatol Venereol. 2013, 27 Suppl 1:7-18. 10.1111\/jdv.12050","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2021.09.004","article-title":"Treatment of imipramine-induced hyperpigmentation with quality-switched ruby and picosecond lasers","volume":"17","author":"Hamid RN","year":"2021","unstructured":"Hamid RN, Yang RG, Munavalli GS. Treatment of imipramine-induced hyperpigmentation with quality-switched ruby and picosecond lasers. JAAD Case Rep. 2021, 17:12-7. 10.1016\/j.jdcr.2021.09.004","journal-title":"JAAD Case Rep"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S142450","article-title":"Review of applications of microneedling in dermatology","volume":"10","author":"Iriarte C","year":"2017","unstructured":"Iriarte C, Awosika O, Rengifo-Pardo M, Ehrlich A. Review of applications of microneedling in dermatology. Clin Cosmet Investig Dermatol. 2017, 10:289-98. 10.2147\/CCID.S142450","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.12520","article-title":"Skin microneedling for acne scars associated with pigmentation in patients with dark skin","volume":"17","author":"Al Qarqaz F","year":"2018","unstructured":"Al Qarqaz F, Al-Yousef A. Skin microneedling for acne scars associated with pigmentation in patients with dark skin. J Cosmet Dermatol. 2018, 17:390-5. 10.1111\/jocd.12520","journal-title":"J Cosmet Dermatol"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.63746","article-title":"Efficacy and safety of platelet-rich plasma in melasma: a systematic review","volume":"16","author":"Alshammari NM","year":"2024","unstructured":"Alshammari NM, Almustafa ZZ, AlBaqshi HN, Abu Jawhar Z. Efficacy and safety of platelet-rich plasma in melasma: a systematic review. Cureus. 2024, 16:e63746. 10.7759\/cureus.63746","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/474291-post-inflammatory-hyperpigmentation-in-skin-of-color-emerging-therapies-and-treatment-algorithms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T14:52:00Z","timestamp":1776437520000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/474291-post-inflammatory-hyperpigmentation-in-skin-of-color-emerging-therapies-and-treatment-algorithms"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":65,"URL":"https:\/\/doi.org\/10.7759\/cureus.107234","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,17]]}}}